JP2014533102A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533102A5
JP2014533102A5 JP2014539995A JP2014539995A JP2014533102A5 JP 2014533102 A5 JP2014533102 A5 JP 2014533102A5 JP 2014539995 A JP2014539995 A JP 2014539995A JP 2014539995 A JP2014539995 A JP 2014539995A JP 2014533102 A5 JP2014533102 A5 JP 2014533102A5
Authority
JP
Japan
Prior art keywords
clonotype
segment
patient
pharmaceutical composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533102A (ja
JP6130387B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061977 external-priority patent/WO2013066726A1/en
Publication of JP2014533102A publication Critical patent/JP2014533102A/ja
Publication of JP2014533102A5 publication Critical patent/JP2014533102A5/ja
Application granted granted Critical
Publication of JP6130387B2 publication Critical patent/JP6130387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539995A 2011-11-04 2012-10-25 強直性脊椎炎の患者間で共有されるt細胞受容体クロノタイプ Active JP6130387B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161556125P 2011-11-04 2011-11-04
US61/556,125 2011-11-04
US201161561234P 2011-11-17 2011-11-17
US61/561,234 2011-11-17
PCT/US2012/061977 WO2013066726A1 (en) 2011-11-04 2012-10-25 T-cell receptor clonotypes shared among ankylosing spondylitis patients

Publications (3)

Publication Number Publication Date
JP2014533102A JP2014533102A (ja) 2014-12-11
JP2014533102A5 true JP2014533102A5 (enExample) 2015-12-10
JP6130387B2 JP6130387B2 (ja) 2017-05-17

Family

ID=48192637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539995A Active JP6130387B2 (ja) 2011-11-04 2012-10-25 強直性脊椎炎の患者間で共有されるt細胞受容体クロノタイプ

Country Status (5)

Country Link
US (2) US20150252422A1 (enExample)
EP (1) EP2773773B1 (enExample)
JP (1) JP6130387B2 (enExample)
ES (1) ES2619713T3 (enExample)
WO (1) WO2013066726A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394567B2 (en) 2008-11-07 2016-07-19 Adaptive Biotechnologies Corporation Detection and quantification of sample contamination in immune repertoire analysis
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
EP2719774B8 (en) 2008-11-07 2020-04-22 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
HUE029424T2 (en) 2009-01-15 2017-02-28 Adaptive Biotechnologies Corp Adaptive immunity profiling and a method for producing monoclonal antibodies
RU2539032C2 (ru) 2009-06-25 2015-01-10 Фред Хатчинсон Кансэр Рисёч Сентер Способ измерения искусственного иммунитета
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
AU2012325791B2 (en) 2011-10-21 2018-04-05 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2867924T3 (es) 2011-12-09 2021-10-21 Adaptive Biotechnologies Corp Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
EP2823060B1 (en) 2012-03-05 2018-02-14 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
DK2831276T3 (da) 2012-05-08 2016-08-01 Adaptive Biotechnologies Corp Sammensætninger og fremgangsmåde til at måle og kalibrere amplifikations-bias i multipleks-PCR-reaktioner
US20160002731A1 (en) 2012-10-01 2016-01-07 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US9708657B2 (en) * 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
AU2015227054A1 (en) 2014-03-05 2016-09-22 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
EP3132059B1 (en) 2014-04-17 2020-01-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
AU2015353581A1 (en) 2014-11-25 2017-06-15 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
ES2858306T3 (es) 2015-02-24 2021-09-30 Adaptive Biotechnologies Corp Método para determinar el estado de HLA mediante secuenciación del repertorio inmunitario
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
CN107345240A (zh) * 2016-05-12 2017-11-14 眭维国 T细胞抗原受体β链CDR3的处理方法
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667967A (en) * 1990-05-01 1997-09-16 The Board Of Trustees Of The Leland Stanford Junior University T-cell receptor varible transcripts as disease related markers
AU736742B2 (en) * 1996-06-03 2001-08-02 Governors Of The University Of Alberta, The Methods for detection of rearranged DNA
CA2626804A1 (en) * 2005-11-01 2007-08-09 Abbott Biotechnology Ltd. Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
ES2261104B1 (es) * 2006-06-19 2007-06-16 Grifols, S.A. "tapon para frascos de productos esteriles y utilizacion de dicho tapon en la dosificacion esteril".
US8748103B2 (en) * 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
KR20110110247A (ko) * 2008-12-30 2011-10-06 센토코 오르토 바이오테크 인코포레이티드 강직성 척추염 환자에서 항-TNFα 항체에 대한 임상적 반응을 예측하는 혈청 마커
KR101323827B1 (ko) * 2010-01-08 2013-10-31 키스트 유럽 에프게엠베하 강직성척추염 진단용 프라이머 및 이를 이용한 강직성 척추염 진단 방법

Similar Documents

Publication Publication Date Title
JP2014533102A5 (enExample)
JP5690588B2 (ja) 肝細胞癌のサブタイプを決定し、肝癌幹細胞を検出するための方法
JP2011188853A5 (enExample)
JP2016519763A5 (enExample)
JP6755241B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
WO2018195328A1 (en) Methods of predicting non-response to anti-tnf treatment in subjects with inflammatory bowel disease
Fleming-Canepa et al. Duck innate immune responses to high and low pathogenicity H5 avian influenza viruses
JP6755240B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP6755242B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP2015530868A5 (enExample)
JP2019518063A5 (enExample)
JP2017532961A (ja) Smad7アンチセンスオリゴヌクレオチドによる対象を処置するための方法および組成物
JP2017532961A5 (enExample)
JP2013518579A5 (enExample)
JP2018504909A5 (enExample)
Brandt et al. Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker
AU2019253079A1 (en) miRNAs for treatment and in vitro diagnosis of drug resistant tumors
US20190249261A1 (en) Methods For Identifying Clonal Mutations And Treating Cancer
Campos Gudino et al. Aberrant HMGA2 expression sustains genome instability that promotes metastasis and therapeutic resistance in colorectal cancer
US20220364184A1 (en) Compositions and methods for treatment of a poor prognosis subtype of colorectal cancer
JP6346493B2 (ja) ペプチドワクチン療法の効果予測方法
CN102787163B (zh) 检测OTOF基因c.1671_1673delG突变的试剂盒
CN102732613A (zh) 检测OTOF基因c.5833delG突变的试剂盒
Iyer et al. SORT LNPs encapsulating Cas9 mRNA achieve efficient editing in skeletal muscle in a dystrophic mouse model
CN105349632A (zh) 原发性高血压易感基因Mfn2的基因变异及其检测方法